[1] |
Wei Jin, Zang Dongjie, Zeng Sanwu, Jiang Jing, Lun Wenhui.
Mutation analysis of the KRT5 gene in a Chinese pedigree with Dowling-Degos disease
[J]. Chinese Journal of Dermatology, 2022, 55(8): 703-705.
|
[2] |
Fan Birao, Chen Xixue, Wang Mingyue.
Retrospective analysis of efficacy and safety of minocycline alone or in combination with low-dose glucocorticoids in the treatment of 15 cases of pemphigus erythematosus and 9 cases of pemphigus herpetiformis
[J]. Chinese Journal of Dermatology, 2022, 55(8): 676-681.
|
[3] |
Cao Miao, Chong Shan, Hu Xinyuan, Zhu Xuejun, Wang Mingyue.
Analysis of skin and mucosal infections and their management after primary tumor resection in patients with paraneoplastic pemphigus
[J]. Chinese Journal of Dermatology, 2022, 55(8): 669-675.
|
[4] |
Jin Liang, Liu Ling.
Treatment of some genodermatoses
[J]. Chinese Journal of Dermatology, 2022, 55(8): 735-739.
|
[5] |
Bao Yingqiu, Zhang Yanjun, Li Bo, Gong Jing, Fu Yu, Xu Zhe.
Gene therapy for recessive dystrophic epidermolysis bullosa
[J]. Chinese Journal of Dermatology, 2022, 55(8): 739-743.
|
[6] |
Zhang Ning, Li Shu, Li Jing .
Efficacy of immune checkpoint inhibitors and targeted therapy in adjuvant treatment of resectable melanoma: a network meta-analysis
[J]. Chinese Journal of Dermatology, 2022, 55(7): 603-609.
|
[7] |
Wang Yuan, Li Zhiliang, Li Suo, Jing Ke, Sun Chao, Liang Guirong, Zhang Hanmei, Feng Suying.
Clinical and immunoserological features of 7 cases of anti-p200 pemphigoid
[J]. Chinese Journal of Dermatology, 2022, 55(7): 557-561.
|
[8] |
Wen Guangdong, Mao Dandan, Zhang Yuanyuan, Dou Yuanqing, Zhao Pei, Wu Chenyu, Zhang Jianzhong.
A case of generalized lichen amyloidosis treated with dupilumab: the first case reported in China
[J]. Chinese Journal of Dermatology, 2022, 55(6): 508-510.
|
[9] |
Working Group for Atopic Dermatitis, Chinese Society of Dermatology, Working Group for Children′s Diseases, Chinese Society of Dermatology.
Treatment of atopic dermatitis with dupilumab: an expert consensus
[J]. Chinese Journal of Dermatology, 2022, 55(6): 465-470.
|
[10] |
Committee on Autoimmune Diseases, China Dermatologist Association.
Cyclosporine in the treatment of immune-related skin diseases: an expert proposal
[J]. Chinese Journal of Dermatology, 2022, 55(6): 471-479.
|
[11] |
Zhao Liuqi, Chen Yan, Chen Danyang, Fan Birao, Wang Rui, Shang Panpan, Chen Xixue, Zhu Xuejun, Wang Mingyue.
Efficacy and safety of dupilumab in the treatment of 21 cases of bullous pemphigoid: a retrospective study
[J]. Chinese Journal of Dermatology, 2022, 55(6): 480-485.
|
[12] |
Li Danqi, Lou Yuchen, Tao Juan.
Application of high-dose intravenous immunoglobulin therapy in severe dermatoses
[J]. Chinese Journal of Dermatology, 2022, 55(5): 455-459.
|
[13] |
Zhang Xiao, Chen Fengming, Liu Lin, Luo Li, Guo Jin, Gao Tianwen, Shi Qiong.
Analysis of clinicopathological features and prognosis of 163 cases of stage Ⅰ cutaneous melanoma
[J]. Chinese Journal of Dermatology, 2022, 55(5): 389-394.
|
[14] |
Shan Ying, Zuo Yagang.
Correlation between autoimmune bullous diseases and psoriasis
[J]. Chinese Journal of Dermatology, 2022, 55(5): 452-455.
|
[15] |
Hu Yebei, Song Xiuzu.
Tranexamic acid for the treatment of melasma
[J]. Chinese Journal of Dermatology, 2022, 55(5): 460-462.
|